HF
ELTX icon

HRT Financial’s Elicio Therapeutics ELTX Stock Holding History

HRT Financial’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$231K Buy
+21,611
New +$209K ﹤0.01% 3096
2021
Q3 		– Sell
-5,986
Closed -$779K – 3406
2021
Q2 		$779K Buy
+5,986
New +$863K 0.01% 1307

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HRT Financial's ELTX Position: Q1 2026 in Review

HRT Financial opened a new position in Elicio Therapeutics (ELTX) in Q1 2026: 21,611 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #3096 among its holdings. This is a return to the name: HRT Financial previously reported a position in ELTX as recently as Q2 2021.

HRT Financial first reported a position in ELTX in Q2 2021 and has held it in 2 quarters since. The position peaked at $779K in Q2 2021. 47 funds tracked by Wall St. Rank hold ELTX as of Q1 2026.

  • HRT Financial held 21,611 shares of Elicio Therapeutics worth $231K as of Q1 2026.
  • Elicio Therapeutics was a new HRT Financial position in Q1 2026.
  • Elicio Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3096 holding.
  • HRT Financial first reported a position in Elicio Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • HRT Financial's Elicio Therapeutics position peaked at $779K in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.